Guangzhou Innogen Pharmaceutical Group Co., Ltd (HKG:2591)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
11.30
-0.54 (-4.56%)
May 28, 2026, 11:49 AM HKT

HKG:2591 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
May '26 Dec '25 Dec '24 Dec '23
5,40913,997--
Enterprise Value
4,25313,255--
Last Close Price
11.8430.64--
PS Ratio
36.9695.64--
PB Ratio
4.6111.94--
P/TBV Ratio
4.7112.19--
EV/Sales Ratio
29.0690.57--
Debt / Equity Ratio
0.160.160.010.07
Net Debt / Equity Ratio
-0.99-0.99-0.99-0.92
Net Debt / EBITDA Ratio
3.063.064.500.88
Net Debt / FCF Ratio
3.293.294.723.67
Asset Turnover
0.110.11--
Inventory Turnover
0.200.20--
Quick Ratio
2.672.675.821.94
Current Ratio
2.932.936.072.66
Return on Equity (ROE)
-36.91%-36.91%-23.27%-
Return on Assets (ROA)
-17.30%-17.30%-11.61%-
Return on Capital Employed (ROCE)
-32.50%-32.50%-23.80%-100.30%
Earnings Yield
-7.02%-2.71%--
FCF Yield
-6.49%-2.51%--
Buyback Yield / Dilution
-3.44%-3.44%-9.63%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.